Notícias da Leica Biosystems

Updates about Leica Biosystems.

Filter by post category:

Quality

Automated Histology Workflow

Academic Research

Digital Pathology

Translational Research

Tumor Microenvironment

Immunofluorescence

Chromogenic multiplexing

Biotechnology Industry

Pharmaceutical Industry

Leica Biosystems Opens New Center of Innovation to Transform Precision Medicine Development

Published: 23 July 2024

Leica Biosystems’ new R&D facility will serve as a hub for collaborative research with leading pharmaceutical and academic institutions. The center aims to speed and streamline the development and commercialization of companion diagnostics. NEWCASTLE UPON TYNE, July 23, 2024 – Leica…

Leica Biosystems and Navinci Partner to Accelerate Cancer Research Through First-Ever Fully Automated In Situ Proximity Ligation Assays

Published: 11 June 2024

Leica Biosystems, a global leader in anatomic pathology, and Navinci, a leader in developing innovative solutions for studying protein interactions, announce a strategic collaboration to drive innovation in cancer patient care. This partnership enables automated in situ proximity ligation assays on…

Leica Biosystems Strengthens Portfolio with FDA Clearance of Class II Mismatch Repair (MMR) Panel

Published: 3 April 2023

The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug Administration (FDA) 510(k) clearance of the BOND MMR Antibody Panel, providing customers…